Advertisement
Screener

PROTO SCRIPT PHARMACEUTICAL CORP Additional Paid in Capital, Common Stock

PROTO SCRIPT PHARMACEUTICAL CORP Additional Paid in Capital, Common Stock

PROTO SCRIPT PHARMACEUTICAL CORP had Additional Paid in Capital, Common Stock of $7.25 million as of 2017-09-30, per its 10-Q filed 2018-03-08.

Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Additional Paid in Capital

us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2018-03-08

  • 2017-09-30: Additional Paid in Capital, Common Stock $7.25M.
  • 2017-06-30: Additional Paid in Capital, Common Stock $7.25M.
  • 2017-03-31: Additional Paid in Capital, Common Stock $7.25M.
  • 2016-12-31: Additional Paid in Capital, Common Stock $6.95M.
Period endAdditional Paid in Capital, Common Stock
2017-09-30$7.25M
10-Q · filed 2018-03-08
2017-06-30$7.25M
10-Q · filed 2018-01-17
2017-03-31$7.25M
10-Q · filed 2017-11-22
2016-12-31$6.95M
10-Q · filed 2018-03-08